Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Clinical trial NCT00595322 · COMPLETED
Trial details
- NCT number
- NCT00595322
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2017-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.